metergoline has been researched along with Depressive Disorder, Major in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Berk, M; Bortolasci, CC; Connor, T; Crowley, TM; Dean, OM; Gray, L; Hernández, D; Jaehne, EJ; Kim, JH; Panizzutti, B; Spolding, B; van den Buuse, M; Walder, K; Yung, AR | 1 |
Barnett, RL; Drake, CL; Feldman-Naim, S; Lowe, CH; Myers, FS; Nawab, SS; Rosenthal, NE; Schwartz, PJ; Turner, EH | 1 |
1 trial(s) available for metergoline and Depressive Disorder, Major
Article | Year |
---|---|
Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Dopamine Agonists; Double-Blind Method; Down-Regulation; Female; Humans; Male; Metergoline; Middle Aged; Phototherapy; Receptors, Serotonin; Seasonal Affective Disorder; Serotonin Antagonists | 2002 |
1 other study(ies) available for metergoline and Depressive Disorder, Major
Article | Year |
---|---|
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen.
Topics: Animals; Antipsychotic Agents; Depressive Disorder, Major; Dizocilpine Maleate; Humans; Metergoline; Methamphetamine; Mice; Transcriptome; Vascular Endothelial Growth Factor A | 2023 |